46
Participants
Start Date
June 30, 2008
Primary Completion Date
May 31, 2014
Study Completion Date
May 31, 2014
Exenatide
Exenatide is given according to current FDA prescribing guidelines. Exenatide and other diabetes medications will be titrated in order to achieve optimal blood glucose levels
Glargine
Subjects will take 1 daily injection of insulin glargine in manner consistent with current prescribing guidelines. Glargine and other diabetes medications will be adjusted to achieve optimal levels of blood sugar control
The University of Michigan Health System, Ann Arbor
Collaborators (1)
Amylin Pharmaceuticals, LLC.
INDUSTRY
Eli Lilly and Company
INDUSTRY
University of Michigan
OTHER